Based on Table 2, the expression level of CLDN18.2 in gastric cancer showed little significant correlation with various clinicopathological characteristics (chi-square and Fisher’s exact tests), except for the level of PD-L1 expression (p = 0.004). Here, CLDN18 is linked to gastric cancer.